|
³ª¿ìÆÊÄÁ¼³Æà |
±Û·Î¹úÁ¦¾à»ç ÀÓ»ó DMBS °æ·Â(°è¾àÁ÷) ä¿ë
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.01 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
»óÀå±â¾÷-ÀÓ»óÆÀÀå ¾÷¹«
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
02.01 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
¿ÜÀÚCRO-Clinical Project Manager
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.26 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
¿ÜÀÚCRO-Regulatory Affair Manager
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.26 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
±¹³»»óÀ§CRO»ç-CRA ¾÷¹«
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.26 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
¿Ü±¹°è CRO»ç-Senior Clincial Research Associate
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.26 |
|
|
Á¦À̾ØÆÄÆ®³ÊÁîÄÚ¸®¾Æ(ÁÖ) |
[¹ÙÀÌ¿À»ç] Medical Doctor ½ÅÀÔ /ÆDZ³
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
½ÅÀÔ |
ä¿ë½Ã |
05.23 |
|
|
JN Partners |
[Áß¼ÒÇü¹ÙÀÌ¿ÀÁ¦¾à»ç ] ½ÅÀÔ CRA/ ½ÅÀÔ RAä¿ë/ ±Û·Î¹ú½ºÅÍ
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
½ÅÀÔ |
ä¿ë½Ã |
01.05 |
|
|
(ÁÖ)¸®¿ÂÆÄÆ®³Ê½º |
Country Head, Manager, Sr./Jr. cra ±Û·Î¹ú Pharm/cro(ÀçÅÃ
¼¿ï °³²±¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
12.01 |
|
|
HRKorea |
ÀÓ»óÆÀ ¸ðÁý
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
»ó½Ãä¿ë |
04.07 |
|
|
(ÁÖ)¸®¿ÂÆÄÆ®³Ê½º |
±Û·Î¹ú Á¦¾à»ç ¿¬±¸ÀÚÁÖµµ ¹× 4»ó ÀÓ»ó
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
12.01 |
|
|
(ÁÖ)ÀâÀ§µå |
[¿Ü±¹°èÁ¦¾à/»ï¼ºµ¿] CRA ä¿ë
¼¿ï °³²±¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
10.03 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
ISS Specialist/±Û·Î¹ú¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
09.08 |
|
|
JYpartners |
Local CRO±â°ü CRA/CRM/Dedicated CRA ±¸ÀÎ
¼¿ï Áß±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
»ó½Ãä¿ë |
05.06 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
MSL(Oncology)/À¯¸í¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
1³â¡è |
ä¿ë½Ã |
08.03 |
|